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Analysis of effectiveness
Data coming from all 22 hospitals were used in the analysis. The telephone survey aimed to interview occupational health staff with respect to the varicella policy in place at their centres, if any. The data retrieved from the interview were as follows: availability of staff information regarding HCW immune status, presence of a varicella policy, and characteristics of the varicella policy.
Effectiveness results
Staff information regarding HCW immune status was available at 21 of the 22 hospitals. These 21 hospitals followed similar policy: exposed non-immune HCWs had to remain off clinical work for minimum periods of 8 to 10 days and those subsequently developing chickenpox had to remain away for a minimum of five days after rash onset, or as long as the rash remained vesicular. A vaccination policy was actually implemented at only one hospital. In the vast majority of hospitals (n=15), the history of varicella infection was obtained and then followed by serology if history was negative or uncertain; in two hospitals history of varicella infection was obtained without any further investigation; in two hospitals, history of varicella infection was obtained and serology was performed only on those working with neonates if history was negative or uncertain; and finally, in two hospitals, all paediatric staff were tested for varicella serology.
Clinical conclusions
The effectiveness analysis showed that UK hospitals usually carry out policies for knowledge of staff varicella immunity, although with different degrees of further investigation when history is uncertain or negative. However, varicella vaccination policies are not routinely implemented.
Measure of benefits used in the economic analysis
No summary benefit measure was used in the economic evaluation, thus the study was classified as a cost-consequences analysis (CCA).
Direct costs
Discounting was not conducted but would have been relevant as costs were incurred over a period of five years. Unit costs were analysed separately from quantities of resources used. The economic analysis focused on two groups of costs: those related to the vaccination exposure due to the lack of a staff varicella policy (replacement time for staff excluded from clinical duties and zoster immunoglobulin (ZIG) therapy) and the predicted costs of implementing a vaccination policy (determination of immune status, counselling, and vaccination of seronegative staff with two doses of vaccine). The cost/resource boundary appears to have been that of the hospital. The estimation of resource use was based on actual data coming from the Radcliffe Hospital, and included episodes involving staff exposed to varicella and infants exposed to potentially infectious nurses. Unit costs were estimated from hospital sources. No price year was reported.
